These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 1332453)
1. Inhibition of leukotriene B4(LTB4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes. Conti P; Panara MR; Barbacane RC; Reale M; Bongrazio M; Dempsey RA Agents Actions; 1992; Spec No():C93-5. PubMed ID: 1332453 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra). Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086 [TBL] [Abstract][Full Text] [Related]
3. Human recombinant IL-1 receptor antagonist (IL-1Ra) inhibits leukotriene B4 generation from human monocyte suspensions stimulated by lipopolysaccharide (LPS). Conti P; Panara MR; Barbacane RC; Bongrazio M; Dempsey RA; Reale M Clin Exp Immunol; 1993 Mar; 91(3):526-31. PubMed ID: 8383025 [TBL] [Abstract][Full Text] [Related]
4. Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures. Conti P; Panara MR; Barbacane RC; Placido FC; Bongrazio M; Reale M; Dempsey RA; Fiore S Cell Immunol; 1992 Nov; 145(1):199-209. PubMed ID: 1330330 [TBL] [Abstract][Full Text] [Related]
5. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist. Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315 [TBL] [Abstract][Full Text] [Related]
6. Generation of leukotrienes by human monocytes pretreated with cytochalasin B and stimulated with formyl-methionyl-leucyl-phenylalanine. Williams JD; Robin JL; Lewis RA; Lee TH; Austen KF J Immunol; 1986 Jan; 136(2):642-8. PubMed ID: 3001181 [TBL] [Abstract][Full Text] [Related]
7. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE. Ferreri NR; Howland WC; Spiegelberg HL J Immunol; 1986 Jun; 136(11):4188-93. PubMed ID: 3009617 [TBL] [Abstract][Full Text] [Related]
8. Assessment of leukotriene B4 synthesis in human lymphocytes by using high performance liquid chromatography and radioimmunoassay methods. Poubelle PE; Borgeat P; Rola-Pleszczynski M J Immunol; 1987 Aug; 139(4):1273-7. PubMed ID: 3039000 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13. Deleuran B; Iversen L; Deleuran M; Yssel H; Kragballe K; Stengaard-Pedersen K; Thestrup-Pedersen K Cytokine; 1995 May; 7(4):319-24. PubMed ID: 8589261 [TBL] [Abstract][Full Text] [Related]
10. Lyprinol inhibits LTB4 production by human monocytes. Dugas B Allerg Immunol (Paris); 2000 Sep; 32(7):284-9. PubMed ID: 11094642 [TBL] [Abstract][Full Text] [Related]
11. Interactions between lipoxin A4, the stable analogue 16-phenoxy-lipoxin A4 and leukotriene B4 in cytokine generation by human monocytes. Andersson P; Serhan CN; Petasis NA; Palmblad J Scand J Immunol; 2004 Sep; 60(3):249-56. PubMed ID: 15320881 [TBL] [Abstract][Full Text] [Related]
12. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. Williams JD; Czop JK; Austen KF J Immunol; 1984 Jun; 132(6):3034-40. PubMed ID: 6327815 [TBL] [Abstract][Full Text] [Related]
13. In vivo inhibition of localized bone resorption by human recombinant interleukin-1 receptor antagonist. Chole RA; Faddis BT; Tinling SP J Bone Miner Res; 1995 Feb; 10(2):281-4. PubMed ID: 7754808 [TBL] [Abstract][Full Text] [Related]
14. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937 [TBL] [Abstract][Full Text] [Related]
15. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells. Mencia-Huerta JM; Razin E; Ringel EW; Corey EJ; Hoover D; Austen KF; Lewis RA J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233 [TBL] [Abstract][Full Text] [Related]
17. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages. Pue CA; Mortensen RF; Marsh CB; Pope HA; Wewers MD J Immunol; 1996 Feb; 156(4):1594-600. PubMed ID: 8568265 [TBL] [Abstract][Full Text] [Related]
18. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187. Palmer RM; Salmon JA Immunology; 1983 Sep; 50(1):65-73. PubMed ID: 6309653 [TBL] [Abstract][Full Text] [Related]
19. Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis. DiPersio JF; Billing P; Williams R; Gasson JC J Immunol; 1988 Jun; 140(12):4315-22. PubMed ID: 2453577 [TBL] [Abstract][Full Text] [Related]